Trial Holdings Inc.

Equities

141A

JP3635490000

Discount Stores

Market Closed - Japan Exchange 02:00:00 2024-04-26 am EDT 5-day change 1st Jan Change
2,709 JPY 0.00% Intraday chart for Trial Holdings Inc. +10.30% 0.00%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Quad/Graphics to Launch In-Store Connect at 15 Save Mart Stores MT
Top Midday Decliners MT
Sector Update: Health Care Stocks Rise in Monday Afternoon Trading MT
Axsome Therapeutics Phase 3 Alzheimer's Treatment Trial is High Risk, High Reward, Morgan Stanley Says MT
Addex Therapeutics Shares Plunge as Phase 2 Study of ADX71149 Falls Short of Primary Goal MT
European Equities Close Mixed in Monday Trading; Economic Sentiment Falls in April; Lawsuit Dents Deutsche Bank Shares MT
Annovis Bio Shares Tumble After Drug Candidate Buntanetap for Alzheimer's Misses Efficacy Endpoint in Phase 2/3 Study MT
BioVie Gets up to $13.1 Million From US Defense Department to Evaluate Bezisterim for Long COVID MT
Sight Sciences Says it Obtained $34 Million Patent Infringement Verdict Against Alcon -- Shares Jump MT
X4 Pharmaceuticals' Xolremdi Approved by FDA For WHIM Syndrome MT
MannKind Gets FDA Approval to Begin Phase 3 Trial of Lung Disease Treatment MT
AIM ImmunoTech Says Safety Evaluation of First Dose Level of Pancreatic Cancer Study Completed MT
Sight Sciences Says it Obtained $34 Million Patent Infringement Verdict Against Alcon -- Shares Jump MT
AstraZeneca Says Enhertu Phase 3 Trial Shows 'Statistically Significant' Progression-Free Breast Cancer Survival Improvement MT
URA rises as emerald mine production starts on time and within budget AN
Abbott's Dissolving Stent Gets FDA Approval For Arteries Below the Knee MT
Annovis Bio reports positive results in mid-stage Alzheimer's treatment trial RE
Prime Medicine Shares Jump After Application for Chronic Granulomatous Disease Treatment Gets FDA Clearance MT
Quadrise continues work on MSAR, bioMSAR fuel trial deal AN
Tech Rally Subsides as US Equity Futures Waver Pre-Bell MT
Prime Medicine Gets FDA Clearance for PM359 IND Application DJ
Top Premarket Decliners MT
Dongcheng Biochemicals' Unit Gets Nod to Trial Tumor Drug MT
Eagle Eye wins one-year AI digital offering deal with Tesco Stores AN
Zenova wins GBP2.4 million paint contract with Drips & Sparks AN
Chart Trial Holdings Inc.
More charts
Trial Holdings Inc is a Japan-based holding company mainly engaged in the distribution and retail business and retail artificial intelligence (AI) business through its subsidiaries. The Company operates through two business segments. The Distribution and Retail segment mainly operates discount stores under the Trial brand that mainly provide daily necessities, home appliances, apparel goods, hobby goods, among others. Store formats include mega center, supercenter (SuC), smart and small store. The Retail Artificial Intelligence (AI) segment mainly provides products and solutions to retailers and food and consumer goods manufacturers that help improve customers' shopping experiences, physical store operations, and the efficiency of advertising and sales promotion activities. The Company also engages in resort-related businesses such as inn facilities and golf course management, as well as construction and real estate management business.
Calendar
More about the company
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
2,709 JPY
Average target price
3,200 JPY
Spread / Average Target
+18.12%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 141A Stock
  4. News Trial Holdings Inc.
  5. AstraZeneca's Biliary Tract Cancer Combo Improves Overall Survival in Late-stage Trial